Enterprise Financial Services Corp (EFSC)’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-814
Closed -$336K – 383
2021
Q3
$336K Buy
814
+797
+4,688% +$331K 0.04% 229
2021
Q2
$6K Hold
17
– – ﹤0.01% 879
2021
Q1
$5K Buy
17
+10
+143% +$2.78K ﹤0.01% 919
2020
Q4
$2K Buy
7
+3
+75% +$714 ﹤0.01% 1079
2020
Q3
$1K Hold
4
– – ﹤0.01% 1169
2020
Q2
$1K Hold
4
– – ﹤0.01% 1173
2020
Q1
$1K Buy
+4
New +$600 ﹤0.01% 1135
2014
Q3
– Sell
-14
Closed -$1K – 1265
2014
Q2
$1K Hold
14
– – ﹤0.01% 1136
2014
Q1
$1K Buy
+14
New +$816 ﹤0.01% 1164

Other funds holding CRL

Enterprise Financial Services Corp (EFSC)'s CRL Position: Q4 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 814 shares — an estimated $336K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in CRL in Q1 2014 and held it in 9 quarters. The position peaked at $336K in Q3 2021. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 814 Charles River Laboratories shares in Q4 2021, an estimated $336K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Charles River Laboratories in Q1 2014 and held it in 9 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Charles River Laboratories position peaked at $336K in Q3 2021.
  • 707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2021, filed 14 Feb 2022.